APSFA Medical Advisory Board
The APSFA is proud to introduce our Medical Advisory Team. These doctors and other professionals help make sure the APSFA provides the most complete and accurate information on our website as well as in our newsletters. Our advisory board members are selected as highly respected experts to provide both depth and range of experience in their specialties.
If you are a physician or researcher and wish to join our Medical Advisory board, please contact us. Thank you.
Doruk Erkan, MD, MPH
Associate Attending Rheumatologist, Hospital for Special Surgery
Associate Physician-Scientist at the Barbara Volcker Center for Women and Rheumatic Diseases
Associate Professor of Medicine at Weill Cornell Medical College
In addition to his rheumatology practice, Dr. Erkan has a long-standing research interest in Antiphospholipid Syndrome (an autoimmune clotting disorder) and Systemic Lupus Erythematosus (SLE or “lupus”). After his Internal Medicine residency at Beth Israel Medical Center in New York, he completed his Rheumatology fellowship at Hospital for Special Surgery in New York. Dr. Erkan has a medical doctor (MD) degree from Hacettepe University School of Medicine in Ankara, Turkey and a master of public health (MPH) degree from Johns Hopkins University School of Public Health in Baltimore, Maryland. Learn more.
Jason Knight, MD, PhD
University of Michigan
Dr. Knight received his MD and PhD degrees from the University of Michigan, and completed his molecular biology Ph.D. research in the laboratory of Dr. Erle Robertson at the University of Pennsylvania. His fellowship in rheumatology was at the University of Michigan, where he received the prestigious American College of Rheumatology Distinguished Fellow Award, as well as a Rheumatology Research Foundation Scientist Development Award. As a faculty member, he has been awarded a Young Physician Scientist Award by the American Society of Clinical Investigation, and a Vic and Kelly Braden Memorial Grant for Lupus Research by the Arthritis National Research Foundation.
Dr. Knight is a leader nationally in the clinical care of APS patients, and especially the role of inflammation in APS. His NIH-funded research laboratory is working to better understand the triggers and effectors of autoimmunity in lupus and the related antiphospholipid syndrome (APS). Contact Dr. Knight if you are interested in participating in APS research studies. Learn more.
Gale A McCarty, MD, FACP, FACR
President, Rheum.Ed Consulting
Active unencumbered medical licensure in CA, DC, and NC
Gale A. McCarty MD FACP FACR (BS, MD, Housestaff, Clinical &Rearch Rheumatology Fellowships, Faculty-Duke) has specialized in clinical research, patient care/education, trainee mentoring, & lupus/anti-phospholipid antibody laboratory testing her entire career (Georgetown, OMRF/Univ of OK, KFSH & Research Centre, Indiana U, UVA, & healthcare systems in ME & CA). She continues her lifelong advocacy for APS/SLE patients thru her private consulting company (Rheum.Ed Consulting) in Santa Monica, the ACR & RRF, & multiple Journal reviewerships. A Member of the Int. Advisory Board for the Vth-XIIIth ISAPA Congresses, she has served on the APSFA Medical Advisory Board since 2006.
Keith R McCrae, MD
Professor, Molecular Medicine
Director, Benign Hematology
Department of Cellular and Molecular Medicine at The Cleveland Clinic
Dr. Keith McCrae’s interest in the causes of abnormal blood clotting in the antiphospholipid syndrome, particularly the interactions of the antiphospholipid antibodies with blood vessels, as well as the roles of circulating microparticles in APS. He is involved in both the clinical care of patients with APS, as well as research into the causes of the disease. He also is interested in other aspects of the APS, including the management of patients with low platelets (thrombocytopenia) and obstetrical disorders. Learn more.
Barry L Myones, MD
Texas Children’s Hospital
Associate Professor, Pediatrics, Baylor College of Medicine
Dr. Barry Myones is a pediatric rheumatologist in Sugar Land, Texas and is affiliated with Texas Children’s Hospital. He received his medical degree from Albany Medical College and has been in practice for more than 20 years. Dr. Myones is one of 5 doctors at Texas Children’s Hospital who specialize in Pediatric Rheumatology. Learn more
Thomas L. Ortel, MD, PhD
Professor of Medicine
Chief – Division of Hematology in the Department of Medicine
Professor of Pathology
Member of the Duke Cancer Institute
Dr. Ortel’s research interests focus on the diagnosis and treatment of patients with bleeding and clotting disorders. He is particularly interested in the immune-mediated clotting disorders, antiphospholipid syndrome (APS) and heparin-induced thrombocytopenia (HIT). Dr. Ortel has participated in multiple studies investigating new anticoagulants (blood thinners) and the use of these therapies in high-risk clinical situations (for example, in the perioperative state and in patients with cancer). His laboratory investigates the mechanisms of clotting and evaluating new anticoagulants. Learn more.
Christopher Repetsky, MD
A native of Cleveland, Ohio, Dr. Repetsky attended the University of Akron for his undergraduate studies. He is a summa cum laude graduate of the American University of Antigua College of Medicine. His professional interests include Primary Care, Neurology, and the application of science-based medicine.
Robert A. S. Roubey, MD
Associate Professor of Medicine, School of Medicine
Division of Rheumatology & Immunology
University of North Carolina at Chapel Hill
Dr. Roubey’s laboratory focuses on the antiphospholipid syndrome, an autoimmune disease in which autoantibodies with an apparent specificity for anionic phospholipids are associated with arterial and venous thrombosis, pregnancy failure, and certain other manifestations. Dr. Roubey is also the Principle Investigator of the Antiphospholipid Syndrome Collaborative Registry (APSCORE), an NIH-funded multicenter disease registry based here at UNC-CH. APSCORE is collecting detailed clinical data and tissue specimens from 2,000 patients with antiphospholipid antibodies and the antiphospholipid syndrome. Registry data and resources will support numerous immunological studies, genetic analyses, and clinical trials.
Founded in 2005, the APS Foundation of America, Inc. is dedicated to fostering and facilitating joint efforts in the areas of education, public awareness, research, and patient services for Antiphospholipid Syndrome (APS) in an effective and ethical manner.
APS Foundation of America, Inc.
P. O. Box 801
LaCrosse, WI 54602-0801
[ Contact Form ]
DISCLAIMER: APS Foundation of America, Inc. website is not intended to replace standard doctor-patient visits, physical examination, and medical testing. Information given to members is only an opinion. All information should be confirmed with your personal doctor. Always seek the advice of a trained physician in person before seeking any new treatment regarding your medical diagnosis or condition. Any information received from APS Foundation of America, Inc. website is not intended to diagnose, treat, or cure. This site is for informational purposes only. Please note that we will be listing all donor or purchaser's names on the Donor page of our foundation site. If you do not want your name listed, please contact us to opt out. If you think you may have a medical emergency, call your doctor or 911 immediately.